A 30-year-old woman presents to the emergency department with breathlessness for the last hour. She is unable to provide any history due to her dyspnea. Her vitals include: respiratory rate 20/min, pulse 100/min, and blood pressure 144/84 mm Hg. On physical examination, she is visibly obese, and her breathing is labored. There are decreased breath sounds and hyperresonance to percussion across all lung fields bilaterally. An arterial blood gas is drawn, and the patient is placed on inhaled oxygen. Laboratory findings reveal: pH 7.34 pO2 63 mm Hg pCO2 50 mm Hg HCO3 22 mEq/L Her alveolar partial pressure of oxygen is 70 mm Hg. Which of the following is the most likely etiology of this patient’s symptoms?
An investigator studying new drug delivery systems administers an aerosol containing 6.7-μm sized particles to a healthy subject via a nonrebreather mask. Which of the following is the most likely route of clearance of the particulate matter in this subject?
A 71-year-old man is admitted to the ICU with a history of severe pancreatitis and new onset difficulty breathing. His vital signs are a blood pressure of 100/60 mm Hg, heart rate of 100/min, respirations of 27/min, temperature of 36.7°C (98.1°F), and oxygen saturation of 85% on room air. Physical examination shows a cachectic male in severe respiratory distress. Rales are heard at the base of each lung. The patient is intubated and a Swan-Ganz catheter is inserted. Pulmonary capillary wedge pressure is 8 mm Hg. An arterial blood gas study reveals a PaO2: FiO2 ratio of 180. The patient is diagnosed with acute respiratory distress syndrome. In which of the following segments of the respiratory tract are the cells responsible for the symptoms observed in this patient found?
A 21-year-old lacrosse player comes to the doctor for an annual health assessment. She does not smoke or drink alcohol. She is 160 cm (5 ft 3 in) tall and weighs 57 kg (125 lb); BMI is 22 kg/m2. Pulmonary function tests show an FEV1 of 90% and an FVC of 3600 mL. Whole body plethysmography is performed to measure airway resistance. Which of the following structures of the respiratory tree is likely to have the highest contribution to total airway resistance?
A 64-year-old man presents to his primary care physician for follow-up of a severe, unrelenting, productive cough of 2 years duration. The medical history includes type 2 diabetes mellitus, which is well-controlled with insulin. He has a 25-pack-year smoking history and is an active smoker. The blood pressure is 135/88 mm Hg, the pulse is 94/min, the temperature is 36.9°C (98.5°F), and the respiratory rate is 18/min. Bilateral wheezes and crackles are heard on auscultation. A chest X-ray reveals cardiomegaly, increased lung markings, and a flattened diaphragm. Which of the following is most likely in this patient?
A 21-year-old man is admitted to the intensive care unit for respiratory failure requiring mechanical ventilation. His minute ventilation is calculated to be 7.0 L/min, and his alveolar ventilation is calculated to be 5.1 L/min. Which of the following is most likely to decrease the difference between minute ventilation and alveolar ventilation?
A 34-year-old woman comes to a physician for a routine health maintenance examination. She moved to Denver 1 week ago after having lived in New York City all her life. She has no history of serious illness and takes no medications. Which of the following sets of changes is most likely on analysis of a blood sample obtained now compared to prior to her move? Erythropoietin level | O2 saturation | Plasma volume
Which of the following physiologic changes decreases pulmonary vascular resistance (PVR)?
A 10-year-old boy is brought to the clinic by his mother with complaints of cough productive of yellow sputum for the past couple of weeks. This is the 4th episode the boy has had this year. He has had recurrent episodes of cough since childhood, and previous episodes have subsided with antibiotics. There is no family history of respiratory disorders. His vaccinations are up to date. He has a heart rate of 98/min, respiratory rate of 13/min, temperature of 37.6°C (99.7°F), and blood pressure of 102/70 mm Hg. Auscultation of the chest reveals an apex beat on the right side of the chest. A chest X-ray reveals that the cardiac apex is on the right. A high-resolution CT scan is performed which is suggestive of bronchiectasis. Which of the following structures is most likely impaired in this patient?
Which of the following cells in the body depends on dynein for its unique functioning?
Explanation: ***Alveolar hypoventilation*** - The patient exhibits features of **obesity** and **labored breathing** with decreased breath sounds and hyperresonance, along with arterial blood gas results showing **respiratory acidosis** (pH 7.34, pCO2 50 mmHg) and **hypoxia** (pO2 63 mmHg). - The calculated A-a gradient (Alveolar O2 - arterial O2) is low (70 mmHg - 63 mmHg = 7 mmHg), indicating that the problem is primarily with **overall ventilation** rather than a defect in gas exchange across the alveolar-capillary membrane. *Right to left shunt* - A right-to-left shunt would cause a **large A-a gradient**, as deoxygenated blood bypasses the lungs and mixes with oxygenated blood. - While it causes **hypoxemia**, it would not typically be associated with hypercapnia unless very severe, and the A-a gradient calculation here does not support a significant shunt. *Ventricular septal defect* - A ventricular septal defect is a **structural heart abnormality** that can cause a left-to-right shunt initially, leading to pulmonary hypertension and eventually a right-to-left shunt (Eisenmenger syndrome). - While it can cause hypoxemia due to shunting, it would not primarily manifest with increased pCO2 or the specific lung physical exam findings of decreased breath sounds and hyperresonance in the absence of other cardiac signs. *Impaired gas diffusion* - Impaired gas diffusion would lead to a **large A-a gradient** and **hypoxemia**, but typically not significant hypercapnia unless the impairment is extremely severe. - Conditions like **pulmonary fibrosis** or **emphysema** cause impaired diffusion, but the patient's presentation and particularly the low A-a gradient do not support this. *Ventilation/perfusion mismatch* - A V/Q mismatch also causes a **large A-a gradient** and **hypoxemia**, as some areas of the lung are either poorly ventilated or poorly perfused. - While it can cause hypercapnia in severe cases, the primary issue indicated by the low A-a gradient here is one of overall inadequate ventilation, not selective areas of ventilation-perfusion imbalance.
Explanation: **Expulsion by the mucociliary escalator** * **Particulate size**: Particles approximately 5-10 μm in size tend to deposit in the **tracheobronchial tree** due to impaction and sedimentation. * **Clearance mechanism**: The **mucociliary escalator** in the bronchioles, bronchi, and trachea effectively traps these particles in mucus and transports them upwards toward the pharynx for swallowing or expectoration. *Trapping by nasal vibrissae* * **Location of deposition**: **Nasal vibrissae** (hairs) primarily trap very large particles (>10 μm) in the nasal passages. * **Particle size**: The 6.7-μm particles are generally too small to be effectively trapped at this initial barrier and would penetrate deeper into the respiratory tract. *Swallowing of nasopharyngeal mucus* * **Mechanism**: While particles cleared by the mucociliary escalator are ultimately swallowed with nasopharyngeal mucus, the primary **route of clearance from the airways** is the mucociliary movement itself. * **Particle size**: Particles of this size would have already bypassed the nasopharyngeal region and deposited deeper in the tracheobronchial tree. *Phagocytosis by alveolar macrophages* * **Location of deposition**: **Alveolar macrophages** are primarily responsible for clearing particles that reach the **alveolar sacs** (typically <0.5-2 μm). * **Particle size**: 6.7-μm particles are too large to efficiently reach the alveoli and would instead be cleared higher up by the mucociliary system. *Diffusion into pulmonary capillaries* * **Mechanism**: Diffusion into pulmonary capillaries is the primary route for **gases** and **very small, soluble particles** (<0.1 μm) to enter the bloodstream. * **Particle size and insolubility**: 6.7-μm particles are too large to diffuse across the alveolar-capillary membrane and are not typically designed for systemic absorption via diffusion.
Explanation: ***Alveolar sacs*** - **Acute respiratory distress syndrome (ARDS)** is characterized by widespread inflammatory injury to the **alveolar-capillary membrane**, leading to increased permeability and fluid accumulation in the alveolar sacs. - The symptoms, including **severe hypoxemia** (PaO2:FiO2 ratio < 300), **non-cardiogenic pulmonary edema** (PCWP ≤ 18 mmHg), and **bilateral lung infiltrates**, directly result from damage to the **Type I and Type II pneumocytes** and endothelial cells within the alveolar units. *Terminal bronchioles* - These are the last airways that **do not contain alveoli**, primarily involved in air conduction rather than gas exchange. - While inflammation can extend to these structures in severe lung injury, the primary site of impaired gas exchange and fluid accumulation in ARDS occurs distal to them, in the respiratory zone. *Bronchi* - The bronchi are primarily involved in **air conduction** and consist of cartilage, smooth muscle, and ciliated epithelium, but they do not participate in gas exchange. - Injury to the bronchi would manifest as airway obstruction or mucus hypersecretion rather than the diffuse alveolar damage seen in ARDS. *Respiratory bronchioles* - These are the first airways that contain a **small number of alveoli** and participate in gas exchange, but their primary role is still more conductive than the alveolar sacs. - Although they can be affected in ARDS, the most critical damage and symptoms arise from the more extensive gas exchange surface of the alveolar sacs. *Bronchioles* - Bronchioles are small airways lacking cartilage, primarily responsible for **airflow regulation** and conduction. - While they can be affected by inflammation, the extensive impairment of gas exchange and the characteristic pathology of ARDS specifically involves the **alveolar units**, not primarily the bronchioles.
Explanation: ***Segmental bronchi*** - In healthy individuals, **medium-sized bronchi** (including segmental and subsegmental bronchi, approximately generations 4-8) contribute approximately **80% of total airway resistance**. - While **Poiseuille's Law** states resistance is inversely proportional to radius to the fourth power (R ∝ 1/r⁴), the key factor is the **total cross-sectional area** and **degree of branching**. - Medium-sized bronchi have moderate individual resistance and **limited parallel branching**, making them the dominant site of resistance. - This is why diseases affecting medium-sized airways (e.g., asthma, bronchitis) cause significant increases in airway resistance. *Terminal bronchioles* - Although individual terminal bronchioles have small radii and high individual resistance, there are **millions of them arranged in parallel**. - With parallel resistances, total resistance decreases: 1/R_total = 1/R₁ + 1/R₂ + 1/R₃... - The **massive number** of small airways means their collective resistance is actually quite **low** (~10-20% of total). - This is why small airways disease is called the "**silent zone**" - significant pathology can occur before detection. *Conducting bronchioles* - These airways also benefit from extensive **parallel branching**, reducing their contribution to total resistance. - They contribute less than medium-sized bronchi due to their large cumulative cross-sectional area. *Respiratory bronchioles* - Part of the **respiratory zone** with the largest total cross-sectional area in the lungs. - Minimal contribution to airway resistance due to enormous parallel arrangement. - Primary function is **gas exchange**, not air conduction. *Mainstem bronchi* - These large airways have **low individual resistance** due to large diameter. - Together with the trachea, they contribute approximately **20% of total airway resistance**. - Not the primary site despite being early in the airway tree.
Explanation: ***Increased pulmonary arterial resistance*** - This patient's long-standing **smoking history**, chronic productive cough, **wheezes**, and **crackles** suggest **Chronic Obstructive Pulmonary Disease (COPD)**, likely including chronic bronchitis and emphysema. - **COPD** often leads to **hypoxia**, causing **pulmonary vasoconstriction** and subsequent increase in **pulmonary arterial resistance**, eventually leading to **pulmonary hypertension** and **cor pulmonale** (right-sided heart failure). *Increased pH of the arterial blood* - Patients with severe COPD and chronic respiratory insufficiency often develop **chronic hypercapnia** (increased **PaCO2**), leading to **respiratory acidosis** and a tendency towards a **decreased pH** or a normal pH with compensation. - An **increased pH** (alkalosis) would be less likely in the context of chronic ventilatory compromise. *Increased cerebral vascular resistance* - In chronic hypercapnia and hypoxia, **cerebral blood vessels** typically **dilate** to maintain cerebral perfusion, leading to **decreased cerebral vascular resistance**, not increased. - This vasodilation can contribute to symptoms like headaches and altered mental status in severe cases. *Decreased carbon dioxide content of the arterial blood* - Patients with chronic obstructive lung disease often have impaired gas exchange, leading to **CO2 retention** (**hypercapnia**). - Therefore, the **arterial carbon dioxide content** would typically be **increased**, not decreased. *Increased right ventricle compliance* - In the setting of chronic **pulmonary hypertension**, the right ventricle is subjected to increased pressure overload, leading to **ventricular hypertrophy** and eventually **decreased compliance** and **ventricular dysfunction**. - **Increased compliance** (meaning the ventricle stretches more easily) is contrary to the expected response in chronic pressure overload.
Explanation: ***Decreasing the physiologic dead space*** - The difference between **minute ventilation (VE)** and **alveolar ventilation (VA)** is the **dead space ventilation (VD)**, calculated as: VE - VA = VD - In this case: 7.0 L/min - 5.1 L/min = 1.9 L/min of dead space ventilation - Decreasing the **physiologic dead space** directly reduces this difference by allowing a greater proportion of each breath to participate in gas exchange - This is the most direct way to narrow the gap between VE and VA *Increasing the partial pressure of inhaled oxygen* - This intervention primarily affects **oxygenation** by increasing the driving pressure for oxygen diffusion into the blood - It does not directly change the volume of air participating in alveolar ventilation or reduce dead space ventilation - The distribution of ventilation between alveolar and dead space remains unchanged *Decreasing the affinity of hemoglobin for oxygen* - A decrease in hemoglobin affinity for oxygen facilitates **oxygen unloading** to the tissues (rightward shift of the oxygen-hemoglobin dissociation curve) - This effect is related to **oxygen delivery** and does not alter the proportion of minute ventilation that reaches the alveoli for gas exchange - Dead space ventilation remains unchanged *Increasing the respiratory depth* - Increasing respiratory depth increases **tidal volume (VT)**, which improves the **ratio** of alveolar ventilation to minute ventilation (VA/VE efficiency) - However, the **absolute difference** (VE - VA) in L/min depends on the **total dead space volume**, which is not changed by increasing tidal volume alone - While this improves ventilation efficiency, it does not directly reduce the dead space ventilation measured in L/min unless physiologic dead space itself decreases *Increasing the respiratory rate* - While increasing respiratory rate increases **minute ventilation (VE)**, it also increases the frequency of ventilating the **dead space** with each breath - Since dead space ventilation (VD) = respiratory rate × dead space volume, increasing rate while keeping tidal volume constant will proportionally increase both VE and VD - This can actually widen the absolute gap between VE and VA, making it less efficient
Explanation: ***↑ ↓ ↓*** - Moving to a high altitude like Denver (from sea level NYC) leads to **hypoxia**, which triggers increased **erythropoietin (EPO)** production to stimulate red blood cell formation. - The immediate physiological response to high altitude is a **decrease in arterial PO2** and thus **oxygen saturation**, along with a **reduction in plasma volume** due to increased diuresis and fluid shifts. *↑ unchanged unchanged* - While **erythropoietin** would increase due to hypoxia at higher altitudes, **oxygen saturation** would decrease, not remain unchanged. - **Plasma volume** also tends to decrease acutely at high altitudes, rather than staying unchanged. *Unchanged ↓ unchanged* - **Erythropoietin** would be expected to increase, not remain unchanged, as a compensatory mechanism to hypoxia. - While **oxygen saturation** would decrease, **plasma volume** typically decreases acutely, not remaining unchanged. *↓ unchanged ↑* - **Erythropoietin** would increase, not decrease, in response to the lower atmospheric oxygen. - Both **oxygen saturation** and **plasma volume** would decrease, not remain unchanged or increase, respectively. *Unchanged unchanged ↓* - **Erythropoietin** would increase, not remain unchanged, to stimulate red blood cell production in response to hypoxia. - **Oxygen saturation** would decrease, not remain unchanged, at higher altitudes.
Explanation: ***Inhaling the entire vital capacity (VC)*** - As lung volume increases from FRC to TLC (which includes inhaling the entire VC), alveolar vessels are **stretched open**, and extra-alveolar vessels are **pulled open** by the increased radial traction, leading to a decrease in PVR. - This **maximizes the cross-sectional area** of the pulmonary vascular bed, lowering resistance. *Inhaling the inspiratory reserve volume (IRV)* - While inhaling IRV increases lung volume, it's not the maximal inspiration of the entire VC where **PVR is typically at its lowest**. - PVR continues to decrease as lung volume approaches total lung capacity (TLC). *Exhaling the entire vital capacity (VC)* - Exhaling the entire vital capacity leads to very low lung volumes, where PVR significantly **increases**. - At low lung volumes, **alveolar vessels become compressed** and extra-alveolar vessels **narrow**, increasing resistance. *Exhaling the expiratory reserve volume (ERV)* - Exhaling the ERV results in a lung volume below FRC, which causes a **marked increase in PVR**. - This is due to the **compression of alveolar vessels** and decreased radial traction on extra-alveolar vessels. *Breath holding maneuver at functional residual capacity (FRC)* - At FRC, the PVR is at an **intermediate level**, not its lowest. - This is the point where the opposing forces affecting alveolar and extra-alveolar vessels are somewhat balanced, but not optimized for minimal resistance.
Explanation: ***Dynein*** - The combination of **recurrent respiratory infections** leading to **bronchiectasis** and **situs inversus** (apex beat on the right, cardiac apex on the right) is characteristic of **primary ciliary dyskinesia (PCD)**, also known as Kartagener syndrome. - **Dynein arms** are crucial for the beating motion of cilia. An impairment in dynein function leads to ineffective ciliary clearance in the respiratory tract and defective embryonic rotation, causing situs inversus. *Neurofilaments* - **Neurofilaments** are intermediate filaments found in neurons, primarily providing structural support to axons. - Their dysfunction is associated with various neurological disorders, but not with respiratory infections or situs inversus. *Kinesin* - **Kinesin** is a motor protein that moves along microtubules, typically transporting cargo away from the cell nucleus (anterograde transport). - While important for intracellular transport, kinesin dysfunction does not explain the specific constellation of symptoms seen in primary ciliary dyskinesia. *Microvilli* - **Microvilli** are actin-filled projections on the surface of some epithelial cells, primarily increasing surface area for absorption. - They are not involved in ciliary motility or mucociliary clearance, and their impairment would not lead to bronchiectasis or situs inversus. *Microfilaments* - **Microfilaments** (actin filaments) are involved in cell shape, motility, and cytokinesis, but are not the primary structural component responsible for ciliary beating. - While integral to many cellular processes, their direct impairment does not cause the specific symptoms of primary ciliary dyskinesia.
Explanation: ***Fallopian tube mucosal cell*** - Dynein is a **motor protein** that facilitates the movement of **cilia** along microtubules. - The ciliary action in fallopian tube mucosal cells is crucial for **transporting the ovum** from the ovary to the uterus. *Small intestinal mucosal cell* - These cells primarily depend on **microvilli** for absorption, which are actin-based structures and do not directly involve dynein for their primary function of absorption. - While they have some cilia, their unique and defining function is nutrient absorption, not movement dependent on dynein. *Skeletal muscle cell* - Skeletal muscle cells rely on the interaction of **actin and myosin** filaments for **contraction**. - Dynein is not directly involved in the mechanism of muscle contraction. *Adipocyte* - Adipocytes are specialized in **lipid storage** and release, a process that does not involve dynein. - Their unique function does not depend on intracellular or extracellular movement facilitated by dynein. *Lower esophageal mucosal cell* - These cells primarily provide a **protective barrier** against gastric acid reflux. - Their function involves **stratified squamous epithelium** and mucus production, not ciliary movement dependent on dynein.
Explanation: ***Body plethysmography*** - This method accurately measures **total lung capacity (TLC)** by applying **Boyle's Law**, assessing pressure and volume changes within an enclosed chamber. - It is superior to gas dilution methods for patients with **air trapping** or **poor ventilation distribution**, as it measures all gas in the chest, including trapped air. *Exhaled nitric oxide* - This test measures **airway inflammation**, particularly in conditions like asthma, but does not assess lung volumes. - It is useful for monitoring treatment response and disease severity but does not provide information about **Total Lung Capacity (TLC)**. *Closed-circuit helium dilution* - This method estimates **lung volumes** by diluting a known concentration of helium, but it underestimates **TLC** in patients with significant **air trapping** because helium cannot equilibrate with unventilated areas. - Given the patient's **barrel chest** suggestive of air trapping, this method would be less accurate for measuring his true TLC. *Spirometry* - Spirometry measures **forced vital capacity (FVC)** and **forced expiratory volume in one second (FEV1)**, which are dynamic lung volumes reflecting airflow limitation. - It does not directly measure **Total Lung Capacity (TLC)** or **residual volume**, as it cannot measure the air remaining in the lungs after maximal exhalation. *Open-circuit nitrogen washout* - This method estimates **functional residual capacity (FRC)** by washing out nitrogen from the lungs with 100% oxygen, but like helium dilution, it can underestimate volumes in patients with **air trapping**. - It provides an estimate of the gas that communicates with the airways, excluding any **trapped gas**.
Explanation: ***FEV1/FVC of 65%*** - This patient's symptoms (shortness of breath, nonproductive cough, worsening with exertion), significant smoking history (40-pack-years), and chest X-ray findings (**hyperinflation**, mildly increased lung markings) are highly suggestive of **Chronic Obstructive Pulmonary Disease (COPD)**, particularly **emphysema** given the hyperinflation and decreased breath sounds. - COPD is characterized by **airflow limitation** that is not fully reversible, which is reflected by a **reduced FEV1/FVC ratio** (typically < 0.7 or < 70%). *Decreased total lung capacity* - **Decreased total lung capacity (TLC)** is characteristic of **restrictive lung diseases**, where lung expansion is limited (e.g., pulmonary fibrosis, interstitial lung disease). - COPD, and especially emphysema, typically presents with **increased TLC** due to air trapping and hyperinflation, not decreased TLC. *Increased DLCO* - **Increased DLCO** (diffusing capacity of the lung for carbon monoxide) can be seen in conditions like **pulmonary hemorrhage** or **asthma**. - In COPD, particularly emphysema, there is destruction of alveolar-capillary membranes, leading to a **decreased DLCO** due to impaired gas exchange. *Metabolic acidosis* - **Metabolic acidosis** is not a primary or direct feature of uncomplicated COPD. While severe respiratory failure in later stages might lead to some acid-base disturbances, directly attributing metabolic acidosis as a defining characteristic is incorrect. - COPD primarily causes **respiratory acidosis** due to CO2 retention in advanced stages. *FEV1/FVC of 80% with an FEV1 of 82%* - An **FEV1/FVC ratio of 80%** (or 0.8) and an **FEV1 of 82%** of predicted values are within the normal range and indicate **normal spirometry**. - This would rule out significant airflow obstruction, which is central to the diagnosis of COPD.
Explanation: ***Defective chloride transport*** - The patient's presentation with **recurrent respiratory infections**, **bronchiectasis** (tram track appearance on CXR), **clubbing**, and **infertility** is highly suggestive of **cystic fibrosis**. - **Cystic fibrosis** is caused by mutations in the **CFTR gene**, leading to **defective chloride transport** across epithelial cells, resulting in thick, viscous secretions. *Fibrosis of the lung parenchyma* - While chronic lung disease can lead to some **pulmonary fibrosis**, it is not the primary underlying pathophysiology described here. - Pulmonary fibrosis typically presents with **restrictive lung disease** and interstitial patterns on imaging, rather than the prominent **bronchiectasis** seen in this patient. *Bronchial hypersensitivity* - This is characteristic of **asthma**, which involves airway inflammation and bronchoconstriction, but typically does not cause the extensive **recurrent infections**, **bronchiectasis**, or **infertility** seen in this case. - Asthma is less likely to result in **clubbing** or the progressive lung damage implied by a "tram track" appearance. *Abnormal ciliary motion* - This describes **primary ciliary dyskinesia (PCD)**, which can also cause recurrent respiratory infections and male infertility due to **immotile sperm**. - However, PCD typically presents with **situs inversus** in a significant proportion of cases and does not involve the characteristic **exocrine gland dysfunction** (e.g., severe abdominal symptoms, pancreatic insufficiency leading to diarrhea) often seen in cystic fibrosis implied by the broad clinical picture. *Gluten hypersensitivity* - Also known as **celiac disease**, this is primarily a **gastrointestinal condition** characterized by malabsorption due to immune reactions to gluten. - While celiac disease can cause **abdominal pain** and **diarrhea**, it does not explain the **recurrent respiratory infections**, **bronchiectasis**, **clubbing**, or **male infertility**.
Explanation: ***Suprachiasmatic nucleus*** - The **suprachiasmatic nucleus (SCN)** is the primary pacemaker of the **circadian rhythm**, regulating the sleep-wake cycle. Damage to this structure, as from prophylactic cranial irradiation, can lead to disruptions in sleep patterns, such as **excessive daytime sleepiness** and prolonged nocturnal sleep. - The SCN receives input from the **retino-hypothalamic tract** and projects to other hypothalamic nuclei to control the secretion of hormones like **melatonin**, which further regulates sleep. *Subthalamic nucleus* - The **subthalamic nucleus** is a component of the basal ganglia motor circuit and is primarily involved in **motor control**. - Dysfunction of this nucleus is typically associated with **movement disorders** like hemiballismus, not sleep disturbances. *Ventromedial nucleus* - The **ventromedial nucleus of the hypothalamus** is primarily involved in regulating **satiety** and metabolism. - Damage to this nucleus is more likely to cause symptoms like **hyperphagia** and obesity, not excessive sleepiness. *Preoptic nucleus* - The **preoptic nucleus** is involved in **thermoregulation** and aspects of sleep regulation, particularly the initiation of NREM sleep. - While it has a role in sleep, the **suprachiasmatic nucleus** is the primary driver of the overall circadian rhythm and sustained excessive sleepiness observed here. *Supraoptic nucleus* - The **supraoptic nucleus** is a neurosecretory nucleus in the hypothalamus responsible for producing **vasopressin (ADH)** and **oxytocin**. - Damage to this nucleus would primarily result in **diabetes insipidus** due to ADH deficiency, not disturbances in the sleep-wake cycle.
Explanation: ***Evaporation*** - In an environment where the ambient temperature (48°C) is **higher than body temperature**, heat gain by convection, conduction, and radiation occurs. Therefore, **evaporation** of sweat is the only significant mechanism for heat loss. - The relatively low humidity (10%) at this high temperature facilitates efficient sweat **evaporation**, which cools the body as it converts liquid sweat into water vapor. *Convection* - **Convection** involves heat transfer through the movement of air or fluid over the body surface. - Since the ambient temperature (48°C) is significantly **above body temperature**, the body would gain heat via convection, not lose it. *Conduction* - **Conduction** is direct heat transfer between objects in contact. - As the ambient temperature (48°C) is much **higher than the skin temperature**, the body would actually **gain heat** through conduction from any surfaces it touched if they were at ambient temperature. *Piloerection* - **Piloerection** (goosebumps) is a mechanism for minimizing heat loss by trapping a layer of warm air close to the skin. - This response is activated in **cold environments** to conserve heat, not in hot environments to dissipate it. *Radiation* - **Radiation** is heat transfer via electromagnetic waves without direct contact. - Since the ambient temperature (48°C) is **higher than body surface temperature**, the body would **gain heat** by radiation, not lose it efficiently, from the surrounding environment.
Explanation: ***Pulmonary vascular resistance is at a minimum*** - When airway pressure equals atmospheric pressure during a pulmonary function test, the lungs are at **functional residual capacity (FRC)** or resting state. - At FRC, **pulmonary vascular resistance (PVR)** is at its lowest point due to the optimal balance between alveolar and extra-alveolar vessel compression/distension. - Extra-alveolar vessels are compressed at low lung volumes, while alveolar vessels are compressed at high lung volumes. At FRC, both are optimally distended, resulting in **minimal PVR**. *Pulmonary vascular resistance is at a maximum* - PVR increases at very low lung volumes (due to extra-alveolar vessel compression) and very high lung volumes (due to alveolar vessel compression). - The resting state (airway pressure equals atmospheric pressure) corresponds to FRC, where PVR is **minimal, not maximal**. *Transmural pressure of the lung-chest wall system is at a maximum* - Transmural pressure of the lung-chest wall system represents the pressure difference across the entire respiratory system. - This pressure is higher during inspiration or forced expiration when the system is stretched or compressed. - At FRC (airway pressure equals atmospheric pressure), the system is at **resting equilibrium**, not at maximal transmural pressure. *Transmural pressure of the chest wall is at a minimum* - Transmural pressure across the chest wall is the difference between intrapleural pressure and atmospheric pressure. - This pressure is not at a minimum when airway pressure equals atmospheric pressure. - Chest wall transmural pressure is actually minimal near **residual volume (RV)**, where the chest wall recoils inward most strongly. *Transmural pressure of the lung-chest wall system is at a minimum* - Transmural pressure of the lung-chest wall system reflects the elastic recoil forces of the combined system. - At FRC (airway pressure equals atmospheric pressure), elastic recoil forces are balanced at equilibrium, but transmural pressure is **not at a minimum**—it represents the neutral resting state.
Explanation: ***Hypothalamus*** - The patient's symptoms of excessive daytime sleepiness, cataplexy (falling asleep with strong emotions like laughter), and hypnagogic hallucinations (sensing someone in the room upon falling asleep) are classic for **narcolepsy**. - Narcolepsy type 1 is characterized by a significant loss of **orexin (hypocretin)** neurons, a neuropeptide primarily produced in the **lateral hypothalamus** (specifically the lateral and perifornical areas), which plays a crucial role in maintaining wakefulness. *Hippocampus* - The **hippocampus** is primarily involved in **memory formation** and spatial navigation. - Deficiencies in neurotransmitters produced or acting in the hippocampus are typically associated with memory disorders, not narcolepsy. *Midbrain* - The **midbrain** contains nuclei involved in dopamine, serotonin, and norepinephrine pathways, which are critical for mood, reward, and sleep-wake regulation. - While these neurotransmitters influence the sleep-wake cycle, the primary deficiency in narcolepsy type 1 is specifically orexin, which originates from the hypothalamus, not the midbrain. *Pons nucleus* - The **pons** is essential for regulating sleep stages, particularly **REM sleep**, and contains nuclei involved in breathing and motor control. - While it contributes to sleep architecture, the core pathology of narcolepsy type 1, the loss of orexin-producing neurons, is located higher in the brain, in the hypothalamus. *Thalamus* - The **thalamus** acts as a crucial relay station for sensory and motor signals to the cerebral cortex and is involved in regulating consciousness and alertness. - While it is involved in arousal regulation, it is not the primary site of orexin production, nor is a neurotransmitter deficiency directly from the thalamus the primary cause of narcolepsy.
Explanation: ***Destruction of cochlear hair cells*** - The patient's age and history of **high-frequency sensorineural hearing loss** on audiometry are characteristic of **presbycusis**, which is primarily caused by **age-related degeneration of cochlear hair cells**. - **Sensory hair cells** in the **basal turn of the cochlea**, which are responsible for detecting high-frequency sounds, are particularly vulnerable to age-related damage and are often the first to be affected. *Bacterial infection of the middle ear* - A bacterial infection of the middle ear, or **otitis media**, would typically present with **ear pain**, **fever**, and signs of inflammation on **tympanic membrane examination**, none of which are noted here. - Furthermore, otitis media primarily causes a **conductive hearing loss**, whereas the patient has **sensorineural hearing loss**. *Increased endolymph production* - **Increased endolymph production** or **Meniere's disease** is characterized by episodic **vertigo**, **tinnitus**, and ** fluctuating sensorineural hearing loss**, often affecting low frequencies initially. - The patient's chronic, progressive high-frequency hearing loss without vertigo does not align with Meniere's disease. *Abnormal skin growth in the middle ear* - An **abnormal skin growth** in the middle ear, or **cholesteatoma**, typically presents with **conductive hearing loss**, **otorrhea (ear discharge)**, and possibly **tinnitus** or **vertigo**. - The patient has **sensorineural hearing loss**, and there is no mention of discharge or other symptoms indicative of a cholesteatoma. *Fixation of the stapes to the cochlea* - **Otosclerosis**, which involves the **fixation of the stapes** to the oval window (not the cochlea), leads to **conductive hearing loss** due to impaired sound transmission to the inner ear. - The patient's audiometry specifically indicates **sensorineural hearing loss**, ruling out otosclerosis as the primary cause.
Explanation: ***Peripheral chemoreceptors*** - In patients with chronic obstructive pulmonary disease (COPD) like this patient, the **central chemoreceptors** become desensitized to chronically elevated CO2 levels. Their primary respiratory drive then shifts to the **peripheral chemoreceptors** (carotid and aortic bodies), which are sensitive to **hypoxia**. - Administering high-flow oxygen **eliminates the hypoxic stimulus** sensed by these normally functioning peripheral chemoreceptors, removing the hypoxic drive to breathe and leading to **hypoventilation, CO2 retention, respiratory acidosis**, and drowsiness (CO2 narcosis). *Pleural pain receptors* - These receptors are primarily involved in sensing pain associated with **pleural inflammation** or injury, contributing to the sensation of pain with breathing. - They do not play a role in regulating the primary ventilatory drive in response to blood gas changes. *Central chemoreceptors* - These receptors are located in the **medulla** and are primarily sensitive to changes in **arterial PCO2** and pH (via H+ ions in CSF). - In chronic respiratory diseases with CO2 retention, they become **desensitized** to elevated CO2, shifting the main respiratory drive to the peripheral chemoreceptors' response to hypoxia. *Airway stretch receptors* - These receptors, including **slowly adapting stretch receptors** and **rapidly adapting irritant receptors**, are located in the airways and respond to lung inflation and irritants. - They are involved in the Hering-Breuer reflex and cough reflex but are not the primary drivers of ventilation in response to hypoxemia. *Pulmonary stretch receptors* - These receptors are located in the **bronchial smooth muscle** and respond to lung distension, contributing to the **Hering-Breuer reflex** which inhibits inspiration to prevent overinflation. - While important for lung mechanics, they do not directly sense blood gas levels to drive ventilation in the context of hypoxia or hypercapnia.
Explanation: ***Carbon monoxide poisoning*** - The patient's symptoms (lethargy, headache, nausea, worse in the morning, and living in a basement) are classic for **carbon monoxide (CO) poisoning**, especially with the unexplained **erythrocytosis** (high hemoglobin and hematocrit). - **Chronic CO exposure** causes tissue hypoxia, which stimulates erythropoietin production leading to **secondary polycythemia** (true increase in red blood cell mass). The elevated red blood cell count in this otherwise healthy young man, living in a basement with likely poor ventilation, points strongly to chronic CO exposure. - Normal pulse oximetry is expected because standard pulse oximeters cannot distinguish between oxyhemoglobin and carboxyhemoglobin. *Exogenous erythropoietin* - While exogenous **erythropoietin** can cause polycythemia (elevated hemoglobin and hematocrit), it is unlikely to cause the constellation of symptoms like headache, lethargy, and nausea without other signs of acute drug effect. - Furthermore, using exogenous erythropoietin for athletic performance enhancement would typically lead to improved, not declined, performance. *Inherited JAK2 kinase mutation* - An inherited **JAK2 kinase mutation** is associated with **polycythemia vera**, which would explain the elevated hemoglobin and hematocrit. - However, polycythemia vera often presents with symptoms like pruritus after bathing, splenomegaly, and thrombotic events, which are not described here, and the symptom onset is less acute than suggested by the "recently moved" detail. *Overuse of NSAIDs* - **NSAID overuse** can cause headaches, but typically not of the waxing and waning severity or associated with lethargy and nausea as described, nor would it explain the elevated hemoglobin and hematocrit. - Long-term NSAID use can lead to gastrointestinal issues or renal problems, but these are not the primary symptoms or lab findings presented. *Increased intracranial pressure* - **Increased intracranial pressure (ICP)** can cause headaches that are worse in the morning and associated with nausea and lethargy. - However, increased ICP alone does not explain the significant **erythrocytosis** found on laboratory testing, which is a key clinical finding.
Explanation: **Decreased physiologic dead space** - During exercise, there is improved perfusion to previously underperfused areas of the lung, leading to a **more uniform ventilation-perfusion (V/Q) matching** and thus a decrease in physiologic dead space. - The increased cardiac output helps to perfuse more capillaries, reducing the amount of ventilated air that does not participate in gas exchange. *Increased apical ventilation-perfusion ratio* - At rest, the **apical V/Q ratio is already high** due to gravity-dependent differences in blood flow; exercise partially normalizes these differences. - While overall V/Q matching improves, the relative V/Q differences between apical and basal regions may become less pronounced, not necessarily a further increase in the apical ratio. *Decreased alveolar-arterial oxygen gradient* - During severe exercise, the **A-a gradient often increases slightly** due to increased oxygen diffusion limitations and V/Q mismatch. - Although overall gas exchange efficiency improves, the sheer volume of oxygen demand can reveal small imbalances, rather than fully eliminating the gradient. *Increased arterial partial pressure of oxygen* - Exercise typically leads to **stable or slightly decreased arterial PO2** in healthy individuals due to the increased metabolic demand and potential small V/Q mismatches. - The body maintains arterial PO2 remarkably well even at high exertion, but it does not usually significantly increase. *Increased pulmonary vascular resistance* - During exercise, **pulmonary vascular resistance (PVR) generally decreases** due to recruitment and distension of pulmonary capillaries. - This decrease in PVR helps to accommodate the increased cardiac output without a significant rise in pulmonary arterial pressure.
Explanation: ***Lecithin production*** - The description of **clustered, cuboidal, foamy-appearing cells** in the lung parenchyma strongly suggests **Type II pneumocytes**. - **Type II pneumocytes** are primarily responsible for producing and secreting **pulmonary surfactant**, which is rich in **lecithin (phosphatidylcholine)**, to reduce surface tension in the alveoli. *Mucus secretion* - **Goblet cells** and **submucosal glands** in the airways are responsible for mucus secretion, not the alveolar cells described. - Mucus functions to trap particles and pathogens, preventing them from reaching the alveoli. *Cytokine release* - While various lung cells, including macrophages and epithelial cells, can release cytokines in response to inflammation or infection, it is not the primary defining function of Type II pneumocytes. - **Cytokine release** is a broad immune response, not specific to the unique morphology and function described. *Toxin degradation* - The liver and kidneys are the primary organs for **toxin degradation** and excretion, though some detoxification can occur in the lungs. - This function is not characteristic of **Type II pneumocytes**, which are focused on surfactant production and alveolar repair. *Gas diffusion* - **Gas diffusion** primarily occurs across the **Type I pneumocytes** (squamous alveolar cells) and the capillary endothelial cells due to their thinness and large surface area. - **Type II pneumocytes** are thicker and less involved in direct gas exchange.
Explanation: ***Equal intrapleural and atmospheric pressures*** - A **puncture wound** in the chest leads to an open connection between the atmospheric air and the **pleural space**. - This equalization of pressures (**pneumothorax**) prevents the lung from expanding during inspiration, as the normal negative intrapleural pressure gradient required for lung inflation is lost. *Paralysis of the diaphragm* - While diaphragm paralysis can cause respiratory distress, it typically presents with **paradoxical breathing** and is not directly indicated by a chest puncture wound. - The primary issue here is a compromise of the **pleural integrity**, not diaphragm function. *Decreased intrapleural pressure* - **Decreased (more negative) intrapleural pressure** is crucial for normal inspiration, allowing the lung to expand. - In this scenario, the intrapleural pressure increases towards atmospheric pressure, explaining the difficulty in breathing. *Increased elastic force of the chest wall pulling it inwards* - The elastic recoil of the chest wall primarily acts to pull the chest *outwards*, while the lungs' elastic recoil pulls *inwards*. - An increase in this force pulling inwards would occur if the lung itself became stiffer, which is not the immediate consequence of a **pneumothorax**. *Diminished inspiratory force due to pain* - While pain can certainly reduce the *effort* of inspiration, the primary mechanical problem in a **pneumothorax** is the inability to create a negative pressure gradient, not just a reduction in muscular force. - Even with full inspiratory effort, the lung cannot inflate effectively if the **pleural space** is open to the atmosphere.
Explanation: ***Alveolar hypoventilation*** - The clinical presentation strongly suggests **foreign body aspiration** causing complete obstruction of the right main bronchus, leading to **alveolar hypoventilation** of the entire right lung. - **Alveolar hypoventilation** means reduced or absent air movement into the alveoli. In this case, the mechanical obstruction prevents ventilation (V/Q = 0), while perfusion continues normally, creating severe V/Q mismatch. - The **hypoxemia unresponsive to 100% FiO2** occurs because blood perfusing the unventilated right lung remains deoxygenated (shunt-like physiology), but the underlying mechanism is **ventilation failure** (hypoventilation), not an anatomical shunt. - **Absent breath sounds** on the right confirm no air entry to that lung, which is the definition of regional hypoventilation. *Right-to-left shunt* - A **true anatomical right-to-left shunt** refers to blood bypassing the lungs entirely through intracardiac defects (VSD, ASD, PDA with Eisenmenger syndrome) or intrapulmonary arteriovenous malformations. - While the obstructed lung creates **shunt-like physiology** (blood passes unventilated alveoli), the mechanism is **hypoventilation due to airway obstruction**, not an anatomical shunt. - The distinction is important: shunt describes the physiological effect (V/Q = 0), but hypoventilation describes the mechanism (airway obstruction preventing ventilation). *Alveolar hyperventilation* - This refers to **increased alveolar ventilation** beyond metabolic needs, leading to increased CO2 elimination and respiratory alkalosis. - The patient shows tachypnea (33/min), which represents compensatory effort, but the right lung has **decreased ventilation** (hypoventilation), not hyperventilation. *Alveolar dead space* - **Alveolar dead space** occurs when alveoli are **ventilated but not perfused** (V/Q approaching infinity), as seen in pulmonary embolism. - This scenario shows the opposite: the right lung is **perfused but not ventilated** due to airway obstruction. *Diffusion limitation* - **Diffusion limitation** occurs when gas exchange across the alveolar-capillary membrane is impaired (pulmonary fibrosis, interstitial lung disease). - This patient has **mechanical obstruction preventing air from reaching the alveoli**, not a problem with diffusion across intact membranes. - Diffusion limitation typically responds partially to supplemental oxygen, unlike complete obstruction.
Explanation: ***Decreased oxygen binding ability of hemoglobin*** - Living at high altitudes leads to **chronic hypoxia**, which stimulates the production of 2,3-diphosphoglycerate (2,3-DPG) in red blood cells. - Increased 2,3-DPG shifts the **oxygen-hemoglobin dissociation curve to the right**, reducing hemoglobin's affinity for oxygen and facilitating oxygen release to tissues, which is an adaptive advantage in low-oxygen environments. *Decreased mean corpuscular hemoglobin concentration* - **Mean corpuscular hemoglobin concentration (MCHC)** is typically maintained within a normal range in response to high altitude. - While there is an increase in hemoglobin concentration (polycythemia) to improve oxygen carrying capacity, the internal hemoglobin content of each red blood cell, and thus MCHC, does not necessarily decrease. *Decreased pulmonary vascular resistance* - Individuals living at high altitudes generally experience **increased pulmonary vascular resistance** due to hypoxic pulmonary vasoconstriction, which can lead to pulmonary hypertension. - A decrease in pulmonary vascular resistance would be counter-intuitive as it would suggest improved rather than challenged pulmonary blood flow in a hypoxic environment. *Decreased red blood cell 2,3-diphosphoglycerate* - **2,3-diphosphoglycerate (2,3-DPG)** levels are actually **increased** in red blood cells at high altitudes. - This increase in 2,3-DPG reduces hemoglobin's affinity for oxygen, promoting oxygen release to the tissues. *Decreased renal erythropoietin production* - Reduced oxygen partial pressure (hypoxia) at high altitudes stimulates the kidneys to **increase erythropoietin production**. - This increased erythropoietin then stimulates the bone marrow to produce more red blood cells (polycythemia), enhancing the oxygen-carrying capacity of the blood.
Explanation: ***Faulty transmembrane ion channel*** - This description is highly suggestive of **cystic fibrosis (CF)**, which is caused by a mutation in the **CFTR (cystic fibrosis transmembrane conductance regulator)** gene, leading to a faulty chloride channel. - The combination of **recurrent respiratory infections** (pneumonia, flu), **malabsorption** (frothy, foul-smelling diarrhea, underweight), and **dehydration** points directly to CF. *Dysfunction of phenylalanine hydroxylase* - This refers to **phenylketonuria (PKU)**, a metabolic disorder characterized by the inability to metabolize phenylalanine. - PKU primarily presents with **intellectual disability**, **seizures**, and **musty odor**, not the respiratory and gastrointestinal symptoms described. *Primary ciliary dyskinesia* - This condition involves dysfunctional cilia leading to recurrent respiratory infections, **bronchiectasis**, and **situs inversus** (Kartagener's syndrome). - While it explains recurrent respiratory issues, it does not account for the **severe malabsorption** and failure to thrive seen in this patient. *Accumulation of branched chain amino acids* - This describes **maple syrup urine disease (MSUD)**, a rare metabolic disorder characterized by the body's inability to break down certain amino acids. - MSUD typically presents with **neurological symptoms** (poor feeding, lethargy, seizures) and a characteristic **sweet-smelling urine** in infancy, not chronic diarrhea and recurrent pneumonia. *Defect in the lysosomal trafficking regulator* - This refers to **Chediak-Higashi syndrome**, a rare autosomal recessive disorder affecting lysosome function. - Key features include **partial albinism**, **recurrent pyogenic infections**, **neurological deficits**, and often **giant lysosomes** in various cells, which do not align with the patient's primary symptoms.
Explanation: ***3200 mL*** - The **functional residual capacity (FRC)** is the volume of air remaining in the lungs after a normal expiration. - It is calculated as the sum of the **expiratory reserve volume (ERV)** and the **residual volume (RV)**. In this case, 1500 mL (ERV) + 1700 mL (RV) = 3200 mL. *4500 mL* - This value represents the sum of the **inspiratory reserve volume (3000 mL)** and the **residual volume (1700 mL)**, which does not correspond to a standard lung volume or capacity. - It does not logically relate to the definition of functional residual capacity. *2000 mL* - This value represents the sum of the **tidal volume (500 mL)** and the **expiratory reserve volume (1500 mL)**, which is incorrect for FRC. - This would represent the inspiratory capacity minus the inspiratory reserve volume, which is not a standard measurement used in pulmonary function testing. *2200 mL* - This value could be obtained by incorrectly adding the **tidal volume (500 mL)** and the **residual volume (1700 mL)**, which is not the correct formula for FRC. - This calculation represents a miscombination of lung volumes that does not correspond to any standard pulmonary capacity measurement. *3500 mL* - This value is the sum of the **tidal volume (500 mL)**, the **expiratory reserve volume (1500 mL)**, and the **residual volume (1700 mL)**. - This would represent the FRC plus the tidal volume, which is not a standard measurement and does not represent the functional residual capacity.
Explanation: ***Macrophages*** - **Alveolar macrophages** are the primary phagocytic cells in the alveoli responsible for clearing inhaled particles that reach this deepest part of the lung. - They engulf and digest foreign substances, including pathogens and inert particles, protecting the delicate alveolar structures. *Goblet cells* - **Goblet cells** are found in the larger airways (trachea, bronchi), where they produce mucus to trap inhaled particles. - They are not present in the alveoli, so they cannot clear particles that have reached this region. *Club cells* - **Club cells** (formerly Clara cells) are located in the bronchioles and secrete components of the surfactant-like material, but they do not primarily function in particle clearance. - While they have some protective roles, they are not the main phagocytic cells for alveolar particles. *Type I pneumocytes* - **Type I pneumocytes** are flattened, thin cells that form the majority of the alveolar surface and are primarily involved in gas exchange. - They are not phagocytic and do not play a direct role in clearing inhaled particles. *Neutrophils* - **Neutrophils** are acute inflammatory cells primarily involved in combating bacterial infections. - While they can migrate to the lungs during inflammation, they are not the primary, routine phagocytic cells for clearing inhaled particles in healthy individuals.
Explanation: ***18 mm Hg*** - **PACO2** is inversely proportional to **alveolar ventilation (VA)**. If ventilation doubles, PACO2 halves assuming constant **CO2 production**. - The patient's respiratory rate has doubled from 14/min to 28/min. Therefore, the new PACO2 will be 36 mmHg / 2 = **18 mm Hg**. *72 mm Hg* - This value would suggest a reduction in **alveolar ventilation**, which is contrary to the increased respiratory rate observed. - If ventilation were halved, PACO2 would double, but the patient is **hyperventilating**. *36 mm Hg* - This is the initial **PACO2** at a respiratory rate of 14/min. - An increase in respiratory rate from 14/min to 28/min will change the **PACO2**. *27 mm Hg* - This value suggests a less than doubling of **alveolar ventilation**, which doesn't align with the doubling of the respiratory rate. - This would imply a more complex change in ventilation beyond simple rate adjustment. *44 mm Hg* - This value would represent a slight increase in **PACO2**, indicating **hypoventilation**. - The patient's increased respiratory rate of 28/min indicates **hyperventilation**, which leads to a decrease in PACO2.
Explanation: ***Probe A: -6 mm Hg; Probe B: 0 mm Hg*** - At the **end of inspiration**, the **intrapleural pressure (Probe A)** is at its most negative, typically around -6 to -8 cm H2O (equivalent to -4 to -6 mmHg), reflecting the maximum expansion of the thoracic cavity. - At the **end of inspiration**, just before exhalation begins, there is **no airflow**, so the **intrapulmonary pressure (Probe B)** equalizes with atmospheric pressure, resulting in a 0 mm Hg reading. *Probe A: 0 mm Hg; Probe B: -1 mm Hg* - An **intrapleural pressure of 0 mm Hg** would indicate a **pneumothorax** since it should always be negative to prevent lung collapse. - An **intrapulmonary pressure of -1 mm Hg** would indicate that **inspiration is still ongoing**, as air would be flowing into the lungs. *Probe A: -4 mm Hg; Probe B: 0 mm Hg* - While an **intrapulmonary pressure of 0 mm Hg** is correct at the end of inspiration, an **intrapleural pressure of -4 mm Hg** is typical for the **end of expiration (Functional Residual Capacity)** during quiet breathing, not the end of inspiration. - The **intrapleural pressure becomes more negative** during inspiration due to increased thoracic volume, so -4 mm Hg would be insufficient. *Probe A: -4 mm Hg; Probe B: -1 mm Hg* - An **intrapleural pressure of -4 mm Hg** is the normal pressure at the **end of expiration**, not the end of inspiration, where it becomes more negative. - An **intrapulmonary pressure of -1 mm Hg** indicates that **inspiration is still in progress**, not at its end, as air would still be flowing into the lungs. *Probe A: -6 mm Hg; Probe B: -1 mm Hg* - While an **intrapleural pressure of -6 mm Hg** is consistent with the end of inspiration, an **intrapulmonary pressure of -1 mm Hg** means that **airflow is still occurring into the lungs**. - At the **very end of inspiration**, just before the start of exhalation, airflow momentarily ceases, and intrapulmonary pressure becomes zero relative to the atmosphere.
Explanation: ***UV-B radiation*** - **UV-B radiation** is the primary cause of sunburn, especially in individuals with **fair skin** who lack sufficient melanin protection and do not use sunscreen. - The distribution of burns on **sun-exposed areas** (face, ears, nose, hands, shoulders, feet) is highly consistent with typical sunburn patterns from direct sunlight exposure. *Child abuse* - While burns can be a sign of child abuse, the described pattern of burns on **regularly sun-exposed areas** in an infant with fair skin and reported lack of sunscreen use is more indicative of accidental sun exposure. - Abusive burns often present with **distinct patterns**, such as immersion burns, contact burns with clear borders, or burns in protected areas, which are not described here. *Gamma radiation* - **Gamma radiation** exposure is typically associated with very severe, deep tissue damage, systemic illness, and often occurs due to accidents involving radioactive materials or during specific medical treatments. - The presented scenario describes **skin burns** consistent with everyday environmental exposure, not high-energy gamma radiation. *Infrared radiation* - **Infrared radiation** primarily causes heat and thermal burns, often from direct contact with hot objects or intense heat sources. - While heat can cause burns, this is distinct from the **sunburn** caused by ultraviolet light, which is more specifically linked to the sun's inflammatory effects on the skin. *Ionizing radiation* - **Ionizing radiation** (which includes gamma rays, X-rays, and alpha/beta particles) causes cell damage through ionization and can result in radiation burns, but these typically occur in highly controlled environments or after significant exposure to radioactive sources. - Sunburn is specifically caused by the **non-ionizing UV spectrum** of radiation.
Explanation: ***Claudin*** - **Claudins** are integral membrane proteins that are primary components of **tight junctions** (zonulae occludentes), which form a diffusion barrier at the **apical aspect** of epithelial cells. - They regulate **paracellular permeability**, crucial for maintaining the integrity of the intestinal epithelial barrier. *Integrin* - **Integrins** are transmembrane receptors that mediate cell-extracellular matrix (ECM) adhesion and cell-cell adhesion, but they are not the primary components of tight junction diffusion barriers. - They are involved in cell signaling and structural support, rather than forming a direct paracellular seal. *Connexon* - A **connexon** is a protein assembly that forms a **gap junction**, allowing direct communication and passage of small molecules between adjacent cells. - Gap junctions facilitate intercellular communication, but do not primarily contribute to sealing the paracellular space as a diffusion barrier. *Desmoglein* - **Desmoglein** is a cadherin family protein found in **desmosomes** (maculae adherens), which are cell-cell adhesion complexes that provide strong mechanical attachments between cells. - Desmosomes resist shearing forces and provide structural integrity but do not regulate paracellular permeability as tight junctions do. *E-cadherin* - **E-cadherin** is a crucial component of **adherens junctions** (zonula adherens), which provide cell-cell adhesion and help establish and maintain cell polarity. - While important for epithelial integrity, E-cadherin primarily links cells to the actin cytoskeleton and is not directly responsible for forming the selective diffusion barrier itself.
Respiratory mechanics and work of breathing
Practice Questions
Pulmonary volumes and capacities
Practice Questions
Spirometry interpretation
Practice Questions
Flow-volume loops
Practice Questions
Airway resistance determinants
Practice Questions
Control of breathing
Practice Questions
Central and peripheral chemoreceptors
Practice Questions
Respiratory centers in the brainstem
Practice Questions
Exercise respiratory physiology
Practice Questions
Sleep effects on respiration
Practice Questions
High altitude adaptation
Practice Questions
Dyspnea mechanisms
Practice Questions
Integrated respiratory responses
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free